Evidence map›Paper›PMID 27752737›Full record

ArticleIntensive care medicine2017

Statins in patients with sepsis and ARDS: is it over? No.

Peter S Kruger, Marius Terblanche

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Intensive care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Innovations in Evaluating Statin Benefit and Efficacy inInternational journal of molecular sciences · 2022
    Review
  3. Review
  4. Short-term protective effect of octreotide on the lungs of rats with experimentally induced sepsis.Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES · 2022
    Article
  5. Review
  6. Review
  7. Article
  8. Update of Sepsis in the Intensive Care Unit.Journal of innate immunity · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Peter S KrugerIntensive Care Unit, Princess Alexandra Hospital, Brisbane, Australia. peter_kruger@health.qld.gov.au.ORCID 0000-0002-3216-2958
Marius TerblancheDivision of Health and Social Care Research, King's College London, London, UK.
King's College London · GBThe University of Queensland · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Disease ProgressionDose-Response Relationship, DrugHumansHydroxymethylglutaryl-CoA Reductase InhibitorsObservational Studies as TopicOutcome Assessment, Health CareRandomized Controlled Trials as TopicRespiratory Distress SyndromeSepsisHydroxymethylglutaryl-CoA Reductase Inhibitors

Identifiers

PMID27752737
OpenAlexW2534867704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.